Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Moore

Showing results (11-20 of 500) with videos related to

Pageof 50
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2006
Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3Bryan Lau, Stephen J Gange, Richard D Moore
AIDS Research and Human Retroviruses|July 3, 2007
Interval and clinical cohort studies: epidemiological issuesBryan Lau, Stephen J Gange, Richard D Moore
Journal of General Internal Medicine|July 1, 2006
Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?Mary Catherine Beach, Jeanne Keruly, Richard D Moore
Journal of General Internal Medicine|January 25, 2003
Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapyKelly A Gebo, Jeanne Keruly, Richard D Moore
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2011
Control of medical comorbidities in individuals with HIVAnne K Monroe, Geetanjali Chander, Richard D Moore
American Journal of Public Health|May 4, 2002
Association of medical insurance and other factors with receipt of antiretroviral therapyJeanne C Keruly, Richard Conviser, Richard D Moore
Journal of Acquired Immune Deficiency Syndromes (1999)|July 5, 2003
Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: a 5-year cohort studyGregory M Lucas, Richard E Chaisson, Richard D Moore
Plos One|July 19, 2011
Association between use of HMG CoA reductase inhibitors and mortality in HIV-infected patientsRichard D Moore, John G Bartlett, Joel E Gallant
AIDS (London, England)|July 9, 2004
Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testingGregory M Lucas, Joel E Gallant, Richard D Moore
Journal of Acquired Immune Deficiency Syndromes (1999)|October 4, 2003
Hospitalization rates differ by hepatitis C satus in an urban HIV cohortKelly A Gebo, Marie Diener-West, Richard D Moore
Pageof 50

Showing results (11-20 of 500) with videos related to

Sort By:
Pageof 50
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2006
Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3Bryan Lau, Stephen J Gange, Richard D Moore
AIDS Research and Human Retroviruses|July 3, 2007
Interval and clinical cohort studies: epidemiological issuesBryan Lau, Stephen J Gange, Richard D Moore
Journal of General Internal Medicine|July 1, 2006
Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?Mary Catherine Beach, Jeanne Keruly, Richard D Moore
Journal of General Internal Medicine|January 25, 2003
Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapyKelly A Gebo, Jeanne Keruly, Richard D Moore
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2011
Control of medical comorbidities in individuals with HIVAnne K Monroe, Geetanjali Chander, Richard D Moore
American Journal of Public Health|May 4, 2002
Association of medical insurance and other factors with receipt of antiretroviral therapyJeanne C Keruly, Richard Conviser, Richard D Moore
Journal of Acquired Immune Deficiency Syndromes (1999)|July 5, 2003
Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: a 5-year cohort studyGregory M Lucas, Richard E Chaisson, Richard D Moore
Plos One|July 19, 2011
Association between use of HMG CoA reductase inhibitors and mortality in HIV-infected patientsRichard D Moore, John G Bartlett, Joel E Gallant
AIDS (London, England)|July 9, 2004
Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testingGregory M Lucas, Joel E Gallant, Richard D Moore
Journal of Acquired Immune Deficiency Syndromes (1999)|October 4, 2003
Hospitalization rates differ by hepatitis C satus in an urban HIV cohortKelly A Gebo, Marie Diener-West, Richard D Moore
Pageof 50